137 related articles for article (PubMed ID: 38467248)
1. Amplification of Mutant NRAS in Melanocytic Tumors With Features of Spitz Tumors.
Cloutier JM; Wang M; Vemula SS; Mirza S; Weier J; Aquino JD; McCalmont TH; LeBoit PE; Bastian BC; Yeh I
Mod Pathol; 2024 May; 37(5):100469. PubMed ID: 38467248
[TBL] [Abstract][Full Text] [Related]
2. Mutated and amplified NRAS in a subset of cutaneous melanocytic lesions with dermal spitzoid morphology: report of two pediatric cases located on the ear.
Dubruc E; Balme B; Dijoud F; Disant F; Thomas L; Wang Q; Pissaloux D; de la Fouchardiere A
J Cutan Pathol; 2014 Nov; 41(11):866-72. PubMed ID: 25263998
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous Melanocytic Tumors With Concomitant NRASQ61R and IDH1R132C Mutations: A Report of 6 Cases.
Macagno N; Pissaloux D; Etchevers H; Haddad V; Vergier B; Sierra-Fortuny S; Tirode F; de la Fouchardière A
Am J Surg Pathol; 2020 Oct; 44(10):1398-1405. PubMed ID: 32732488
[TBL] [Abstract][Full Text] [Related]
4. Spitz melanoma is a distinct subset of spitzoid melanoma.
Raghavan SS; Peternel S; Mully TW; North JP; Pincus LB; LeBoit PE; McCalmont TH; Bastian BC; Yeh I
Mod Pathol; 2020 Jun; 33(6):1122-1134. PubMed ID: 31900433
[TBL] [Abstract][Full Text] [Related]
5. Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report.
Vachtenheim J; Kodet R; Fischer O; Kolek V; Strizova Z; Ozaniak A; Simonek J; Stolz A; Pozniak J; Kolarik J; Svorcova M; Vachtenheim J; Lischke R
Diagn Pathol; 2020 Oct; 15(1):132. PubMed ID: 33100226
[TBL] [Abstract][Full Text] [Related]
6. BRAF and NRAS mutations in spitzoid melanocytic lesions.
Fullen DR; Poynter JN; Lowe L; Su LD; Elder JT; Nair RP; Johnson TM; Gruber SB
Mod Pathol; 2006 Oct; 19(10):1324-32. PubMed ID: 16799476
[TBL] [Abstract][Full Text] [Related]
7. Restrospective reappraisal of the prognostic classification of spitzoid melanocytic neoplasms after BRAF and NRAS mutation characterisation: a single institution experience.
Moysset I; Castrejon N; Garcia-Herrera A; Castillo P; Marginet M; Teixido C; Podlipnik S; Albero-Gonzalez R; Montironi C; Navarro J; Rovira C; Puig S; Carrera C; Alos L
Histopathology; 2024 Jun; 84(7):1154-1166. PubMed ID: 38409889
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions.
Busam KJ; Kutzner H; Cerroni L; Wiesner T
Am J Surg Pathol; 2014 Jul; 38(7):925-33. PubMed ID: 24698967
[TBL] [Abstract][Full Text] [Related]
9. PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features.
Raghavan SS; Wang JY; Kwok S; Rieger KE; Novoa RA; Brown RA
J Cutan Pathol; 2020 Dec; 47(12):1123-1131. PubMed ID: 32700786
[TBL] [Abstract][Full Text] [Related]
10. Spitz nevi and Spitzoid melanomas: exome sequencing and comparison with conventional melanocytic nevi and melanomas.
Lazova R; Pornputtapong N; Halaban R; Bosenberg M; Bai Y; Chai H; Krauthammer M
Mod Pathol; 2017 May; 30(5):640-649. PubMed ID: 28186096
[TBL] [Abstract][Full Text] [Related]
11. MAP2K1-mutated melanocytic tumors have reproducible histopathologic features and share similarities with melanocytic tumors with BRAF V600E mutations.
Alomari AK; Harms PW; Andea AA; Warren SJ
J Cutan Pathol; 2023 Dec; 50(12):1083-1093. PubMed ID: 37565534
[TBL] [Abstract][Full Text] [Related]
12. Spitz Tumors With ROS1 Fusions: A Clinicopathological Study of 6 Cases, Including FISH for Chromosomal Copy Number Alterations and Mutation Analysis Using Next-Generation Sequencing.
Donati M; Kastnerova L; Martinek P; Grossmann P; Sticová E; Hadravský L; Torday T; Kyclova J; Michal M; Kazakov DV
Am J Dermatopathol; 2020 Feb; 42(2):92-102. PubMed ID: 31361613
[TBL] [Abstract][Full Text] [Related]
13. Attempting to Solve the Pigmented Epithelioid Melanocytoma (PEM) Conundrum: PRKAR1A Inactivation Can Occur in Different Genetic Backgrounds (Common, Blue, and Spitz Subgroups) With Variation in Their Clinicopathologic Characteristics.
de la Fouchardiere A; Tirode F; Castillo C; Buisson A; Boivin F; Macagno N; Pissaloux D
Am J Surg Pathol; 2022 Aug; 46(8):1106-1115. PubMed ID: 35319526
[TBL] [Abstract][Full Text] [Related]
14. Amplification of mutated NRAS leading to congenital melanoma in neurocutaneous melanocytosis.
Salgado CM; Basu D; Nikiforova M; Hamilton RL; Gehris R; Jakacki R; Panigrahy A; Yatsenko S; Reyes-Múgica M
Melanoma Res; 2015 Oct; 25(5):453-60. PubMed ID: 26266759
[TBL] [Abstract][Full Text] [Related]
15. Integrating Next-Generation Sequencing with Morphology Improves Prognostic and Biologic Classification of Spitz Neoplasms.
Quan VL; Zhang B; Zhang Y; Mohan LS; Shi K; Wagner A; Kruse L; Taxter T; Beaubier N; White K; Zou L; Gerami P
J Invest Dermatol; 2020 Aug; 140(8):1599-1608. PubMed ID: 32004563
[TBL] [Abstract][Full Text] [Related]
16. Spitz nevus in a Hispanic population: a clinicopathological study of 130 cases.
Berlingeri-Ramos AC; Morales-Burgos A; Sánchez JL; Nogales EM
Am J Dermatopathol; 2010 May; 32(3):267-275. PubMed ID: 20098300
[TBL] [Abstract][Full Text] [Related]
17. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
18. Cross-reactivity of NRASQ61R antibody in a subset of Spitz nevi with 11p gain: a potential confounding factor in the era of pathway-based diagnostic approach.
Parra O; Lefferts JA; Tafe LJ; Gru AA; Linos K
Hum Pathol; 2021 Jun; 112():35-47. PubMed ID: 33636207
[TBL] [Abstract][Full Text] [Related]
19. The genomic landscape of childhood and adolescent melanoma.
Lu C; Zhang J; Nagahawatte P; Easton J; Lee S; Liu Z; Ding L; Wyczalkowski MA; Valentine M; Navid F; Mulder H; Tatevossian RG; Dalton J; Davenport J; Yin Z; Edmonson M; Rusch M; Wu G; Li Y; Parker M; Hedlund E; Shurtleff S; Raimondi S; Bhavin V; Donald Y; Mardis ER; Wilson RK; Evans WE; Ellison DW; Pounds S; Dyer M; Downing JR; Pappo A; Bahrami A
J Invest Dermatol; 2015 Mar; 135(3):816-823. PubMed ID: 25268584
[TBL] [Abstract][Full Text] [Related]
20. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
